Board-certified Neurologist with 12+ years of experience in academia and research specializing in rare diseases, with therapeutic expertise in Muscular Dystrophy, Spinal Muscular Atrophy, Myasthenia Gravis, Neuropathy, and Charcot-Marie-Tooth disease.
I am a Medical Director of Neurology- Medical Affairs at PRA Health Sciences, responsible for providing medical expertise on all phases of clinical drug development, including study protocol conception, clinical trial oversight, regulatory submissions and publications. Prior to this, I was the Medical Director of the Muscular Dystrophy Program at the University of Michigan at Ann Arbor, where I provided care for over 2000 patients with rare neuromuscular diseases, with a research focus on development and validation of outcome measures for clinical trials, increasing the pipeline of available therapies and improving patient quality of life.
Please visit my linkedin page to learn more about me.
Thank you for visiting!